The findings of the first study ever on how LSD (lysergic acid diethylamide) affects the brain have been released and its results might help LSD join ketamine a.k.a. "special K" as a treatment for ...
Taking tiny, frequent amounts of the psychedelic drug lysergic acid diethylamide (LSD) might temporarily elevate mood for people diagnosed with major depressive disorder. In a small pilot study, ...
A new study published last month examined the influence of LSD on brain connections, yielding some enlightening results. The study, published in the Journal of Psychopharmacology, found that the “drug ...
The magical and potent hallucinogen lysergic acid diethylamide (LSD) may have a new, clinically significant medical benefit: getting sleep. A new study, entitled “LSD Increases Sleep Duration the ...
In 1957, when the British psychiatrist Humprhey Osmond was looking to coin a word for the mind-bending effects of LSD, he wrote a letter to his friend Aldous Huxley. The "Brave New World" author — who ...
May didn’t notice much with the first dose of LSD. She felt good, and she got a lot accomplished, and that was all. It was the day after that things really clicked. She felt even better, and she got a ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. WASHINGTON (AP) — LSD reduced symptoms of ...
Ongoing neuroscience research on psychedelic drugs like LSD and psilocybin is increasingly demonstrating the healing potential of these substances. In the case of LSD, researchers note in a recent ...
Would you pay money to support a scientific experiment involving illegal drugs? A group of British scientists started a crowdfunding campaign to raise the remaining 25,000 pounds (about $37,600) ...
Real-world results: Swiss hospitals saw strong mental health improvements in patients given LSD or psilocybin with psychotherapy under a compassionate use program. Safe in clinics: No serious side ...
BASEL, Switzerland, Feb. 17, 2021 /PRNewswire/ -- MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company, announced the start of a study for its LSD neutralizer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results